Europe

Celgene: European Decision Not Best Case Scenario, Not Worst Case Either
Barron's
Fri, 12/19/14 - 04:03 pm
Celgene
Europe
Revlimid
Orexigen diet pill recommended for approval in Europe
Yahoo/Reuters
Fri, 12/19/14 - 09:46 am
Orexigen
obesity
Contrave
Europe
Mysimba
AstraZeneca first-in-class ovarian cancer drug wins EU approval
Yahoo/Reuters
Thu, 12/18/14 - 09:01 am
AstraZeneca
ovarian cancer
Europe
Lynparza
olaparib
Celgene Hits 52-Week High on Positive CHMP Opinion
Yahoo/Zacks.com
Mon, 12/1/14 - 07:31 pm
Celgene
CHMP
Europe
Otezla
Novartis says heart-failure drug wins faster review in Europe
Yahoo/Reuters
Sat, 11/29/14 - 10:30 am
Novartis
heart failure
Europe
LCZ696
Once-weekly Lilly diabetes drug wins EU approval
Yahoo/Reuters
Tue, 11/25/14 - 03:19 pm
Eli Lilly
diabetes
Europe
Trulicity
Europe gives green light to AbbVie hepatitis C medicine, others
Yahoo/Reuters
Fri, 11/21/14 - 08:11 am
Europe
AbbVie
hepatitis C
dasabuvir
Sanofi
eliglustat
Novartis
secukinumab
Merck
Vorapaxar
Boehringer Ingelheim
nintedanib
Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni
TheStreet.com
Tue, 11/18/14 - 10:59 am
Gilead Sciences
Harvoni
Europe
hepatitis C
For This Obesity Drug, Europe Trumps the U.S.
Motley Fool
Tue, 11/18/14 - 10:06 am
Orexigen
Europe
Contrave
obesity
Orexigen Therapeutics (OREX) Stock Continues to Rise as EU Reviews Contrave Drug
TheStreet.com
Mon, 11/10/14 - 04:08 pm
Orexigen
Contrave
Europe
Glaxo files regulatory submissions for asthma drug candidate
Seeking Alpha
Wed, 11/5/14 - 09:31 am
GSK
asthma
Europe
mepolizumab
AstraZeneca ovarian cancer drug wins European green light
Yahoo/Reuters
Fri, 10/24/14 - 07:31 am
AstraZeneca
ovarian cancer
Europe
Lynparza
olaparib
AstraZeneca looks to EU decision for next cancer drug boost
Yahoo/Reuters
Tue, 10/14/14 - 09:48 am
AstraZeneca
Europe
olaparib
ovarian cancer
Medtronic seeks EU approval for $43 bln Covidien deal
Yahoo/Reuters
Mon, 10/13/14 - 09:43 am
Medtronic
Europe
M&A
Covidien
devices
Does Gilead Sciences Have a European Problem?
Barron's
Wed, 10/8/14 - 01:07 pm
Gilead Sciences
Europe
Sovaldi
EU OKs Eli Lilly's $5.4B bid for Novartis division
Yahoo/AP
Fri, 10/3/14 - 07:57 am
Europe
Eli Lilly
Novartis
animal health
EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal - sources
Yahoo/Reuters
Thu, 10/2/14 - 10:34 am
Europe
Zimmer
Biomet
Eli Lilly
Novartis
M&A
devices
animal heatlh
Gilead’s Hepatitis C Combination Wins EU Agency Backing
Bloomberg
Fri, 09/26/14 - 09:02 am
Gilead Sciences
hepatitis C
Europe
Sovaldi
ledipasvir
Cubist extends superbug R&D to Europe
Pharmaphorum
Thu, 09/18/14 - 09:27 am
Cubist Pharmaceuticals
Europe
R&D
antibiotics
antibiotic resistance
EU to decide on $52 bln AbbVie, Shire deal by Oct. 16
Yahoo/Reuters
Mon, 09/15/14 - 10:24 am
Europe
AbbVie
Shire

Pages